Larvol Delta - Study-of-ALEC04-in-Patients-With-Head-and-Neck-Cancer

ALE.C04 - Alentis Therap

Keytruda (pembrolizumab) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT06054477

Feb 18, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next